Diabetic neuropathy. Autonomic neuropathy in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: For patients in this group for local magnetic therapy, a leather wristband with a neodymium bipolar magnet with an average magnetic intensity of 155 mTesla in the s
Sponsors
Gonabad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Diabetes type 2; diagnosed by a diabetologist according to American Diabetes Association (ADA) standards Diabetic peripheral neuropathy at least 6 scores on the Neuropathy disability score (NDS) without Neuropathy Symptoms score (NNS) or 3-5 scores on NDS with at least 5 scores on NSS Drug-refractory neuropathic pain intensity at least 1 score on Visual analogue scale Able to complete questionnaires and willing to sign written informed consent Aged 18–70 years (either sex)
Exclusion criteria
Exclusion criteria: Pregnancy, planning a pregnancy, lactation Had any of the following: Vascular insufficiency, Renal failure, Metallic implantation, Skin diseases, Foot ulcers, Prosthesis, Prior magnetic therapy, Cardiac pacemaker, Mechanical insulin pump or any electronic device Had diabetic peripheral neuropathy from other causes than diabetes (according to the medical history and diagnosis of specialist doctors) Opiate or drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of clinical symptoms of diabetic neuropathy. Timepoint: At the beginning of the study and 4, 8 and 12 weeks after the start of the intervention. Method of measurement: Neuropathy symptom score questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of neuropathic pain. Timepoint: The beginning of the study and weeks 4, 8 and 12. Method of measurement: Visual analogue scale questionnaire.;Severity of neuropathy disability. Timepoint: The beginning of the study and the 12th week after the start of the intervention. Method of measurement: neuropathy disability score questionnaire.;Quality of life. Timepoint: The beginning of the study and the 12th week after the start of the intervention. Method of measurement: NeuroQol questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArmin Nazeri
Gonabad University of Medical Sciences
Outcome results
None listed